StockNews.com Initiates Coverage on Aethlon Medical (NASDAQ:AEMD)

Stock analysts at StockNews.com began coverage on shares of Aethlon Medical (NASDAQ:AEMD) in a report released on Sunday. The brokerage set a “sell” rating on the medical equipment provider’s stock.

Separately, HC Wainwright reaffirmed a “buy” rating and issued a $7.00 price objective on shares of Aethlon Medical in a report on Friday, November 15th.

Aethlon Medical Trading Down 7.1 %

Shares of AEMD opened at $0.66 on Friday. Aethlon Medical has a 12 month low of $0.24 and a 12 month high of $2.10. The firm’s 50 day moving average is $0.52 and its 200-day moving average is $0.44. The stock has a market capitalization of $9.27 million, a PE ratio of -0.24 and a beta of 1.61.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.